Cloned (Comment) | Organism |
---|---|
expression of His-Myc-tagged wild-type enzyme and tagged mutant E385A, as well as truncated construct comprising the amino acid residues 549-951, in the carcinoma cell line T47D | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
E385A | point mutation in the zinc binding domain, catalytically inactive mutant | Homo sapiens |
additional information | induction of tumor growth in nude mice by injection of carcinoma cells, cell line T47D expressing the recombinant His-Myc-tagged wild-type or mutant E385A enzyme, number and distribution of vessels in the tumors are reduced compared to control tumors, high degree of edema and necrosis, the truncated construct comprising the amino acid residues 549-951 had no effect on tumor growth, but the isolated first TSP1 repeat does | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
extracellular | secretion | Homo sapiens | - |
- |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | interaction with heparin via the first TSP1 domain at the C-terminal part, enzyme shows an antiangiogenic effect, the enzyme is able to shed proteins from the surface of the endothelium | ? | - |
? | |
proteins + H2O | Homo sapiens | - |
peptides | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
proteolytic degradation of proteins | C-terminal catalytic domain | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
T47-D cell | low expression level | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | vascular endothelial growth factor 165 and vascular endothelial growth factor 165 receptor tyrosine kinase are no substrates for proteolytic cleavage, but the enzyme blocks endothelial vascularization by inhibiting the necessary phosphorylation of the receptor | Homo sapiens | ? | - |
? | |
additional information | interaction with heparin via the first TSP1 domain at the C-terminal part, enzyme shows an antiangiogenic effect, the enzyme is able to shed proteins from the surface of the endothelium | Homo sapiens | ? | - |
? | |
proteins + H2O | - |
Homo sapiens | peptides | - |
? | |
proteins + H2O | rather restricted substrate specificity | Homo sapiens | peptides | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ADAMTS1 | - |
Homo sapiens |
M12.222 | Merops-ID | Homo sapiens |
METH1 | - |
Homo sapiens |